DENdritic Cell Immunotherapy for Mesothelioma

A target of 230 subjects satisfying all study criteria, will be randomized to receive either dendritic cell therapy plus best supportive care (Arm A) or best supportive care alone (Arm B). Subjects in Arm A will undergo leukapheresis to obtain monocytes … (본문 전체 8/2/2018 6:09 PM)

41 thoughts on “DENdritic Cell Immunotherapy for Mesothelioma”

Leave a Comment